Varicella-Zoster Virus (VZV) Meningitis in an Immunocompetent Adult after BNT162b2 mRNA COVID-19 Vaccination: A Case Report.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 23 12 2021
revised: 29 03 2022
accepted: 01 04 2022
pubmed: 11 4 2022
medline: 18 5 2022
entrez: 10 4 2022
Statut: ppublish

Résumé

We present, to our knowledge, the second case report of a 46-year old female who developed varicella-zoster virus (VZV) meningitis after BNT162b2 mRNA COVID-19 vaccination. The patient is immunocompetent and has no known predisposing risk factors for developing VZV meningitis. The patient received acyclovir therapy and subsequently had a complete recovery. We describe possible mechanisms of VZV meningitis after mRNA COVID-19 vaccination.

Identifiants

pubmed: 35398296
pii: S1201-9712(22)00200-4
doi: 10.1016/j.ijid.2022.04.001
pmc: PMC9058432
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0
RNA, Messenger 0
BNT162 Vaccine N38TVC63NU

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

184-186

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

N Engl J Med. 2021 Jul 15;385(3):239-250
pubmed: 34043894
Clin Microbiol Infect. 2022 Jan;28(1):130-134
pubmed: 34592420
Int J Infect Dis. 2021 Oct;111:169-171
pubmed: 34428545
J Am Soc Nephrol. 2021 Oct 19;:
pubmed: 34667083
N Engl J Med. 2021 Sep 16;385(12):1078-1090
pubmed: 34432976
Rheumatology (Oxford). 2021 Oct 9;60(SI):SI90-SI95
pubmed: 33848321
Vaccines (Basel). 2021 Jun 01;9(6):
pubmed: 34205861
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Int J Infect Dis. 2021 Dec;113:55-57
pubmed: 34587536
N Engl J Med. 2021 Nov 18;385(21):2010-2012
pubmed: 34648703
Front Cell Infect Microbiol. 2012 Oct 08;2:122
pubmed: 23061052
Front Immunol. 2019 Mar 27;10:594
pubmed: 30972078
Front Immunol. 2021 Sep 28;12:740708
pubmed: 34650563

Auteurs

R Medhat (R)

Associate Staff Physician, Hospital Medicine, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE, p.o box 112412. Electronic address: MedhatR@ClevelandClinicAbuDhabi.ae.

R El Lababidi (R)

AAHIVP, Senior Manager, Pharmacy Education and Training, Co-Director, Antimicrobial Stewardship Program, Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, UAE. p.o box 112412. Electronic address: ellabar@clevelandclinicabudhabi.ae.

M Abdelsalam (M)

Pharmacy Intern, Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE, p.o. box 112412. Electronic address: AbdelsM2@ClevelandClinicAbuDhabi.ae.

A Nusair (A)

Professor of Medicine. John C. Edwards School of Medicine Marshall University, Huntington, West Virginia. Electronic address: nusair@marshall.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH